Sponsor · clinical trials

Haukeland University Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Norway, Sweden, Netherlands, Denmark and Poland registers with Haukeland University Hospital as lead sponsor. Synced 14 Nov 2026

80Current trials

40Recruiting now

19Drugs in these trials

5Trial registers

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 14 Nov 2026 · Editorial standards

At a glance

Haukeland University Hospital is the lead sponsor of 80 current clinical trials in our Norway, Sweden, Netherlands, Denmark and Poland registers. 40 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Cyclophosphamide, Ocrelizumab and Alemtuzumab. The most-studied condition is Multiple Sclerosis.

ClinicalTrials.gov trials by status

Recruiting4050%
Not yet open810%
Active, closed2734%
By invitation56%

Trials by phase

Not applicable4658%
Observational1721%
Phase 2911%
Phase 334%
Phase 1/234%
Phase 411%
Phase 111%

Clinical trials sponsored by Haukeland University Hospital

80 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Effectiveness of a Digital Application for Adolescents With Mild to Moderate Anxiety NCT06531980 · Anxiety, Anxiety and Fear, Adolescent - Emotional Problem	Not applicable	Recruiting	2025-01	Norway
Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families NCT05744310 · ClinicalTrials.gov ↗ · Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Nervous System Diseases	Not applicable	Recruiting	2023-04	Norway
Primary Aldosteronism in Western Norway NCT02832388 · ClinicalTrials.gov ↗ · Hyperaldosteronism	Observational	Recruiting	2013-06	Norway
Emotional Dysregulation in Para-suicidal Behavior NCT03846375 · ClinicalTrials.gov ↗ · Self Harm, Suicide, Attempted, Emotional Instability	Not applicable	Recruiting	2019-01	Norway
Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism NCT06495983 · ClinicalTrials.gov ↗ · Mineralocorticoid Excess, Primary Aldosteronism, Hypercortisolism	Observational	Recruiting	2024-06	Norway
Improving Diagnostics and Care After First Seizure NCT06814665 · ClinicalTrials.gov ↗ · First Suspected Epileptic Seizure	Observational	Recruiting	2025-01	Norway
N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease NCT07741071 · ClinicalTrials.gov ↗ · Alzheimer Disease (AD)	Phase 2	Recruiting	2026-08	Norway
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression NCT07312110 · ClinicalTrials.gov ↗ · Parkinson s Disease, Parkinson Disease (PD)	Phase 2	Recruiting	2026-01	Norway
Neurobiological Markers of Treatment Response for Anxiety and OCD NCT05663489 · ClinicalTrials.gov ↗ · Obsessive-Compulsive Disorder, Social Anxiety Disorder, Panic Disorder	Observational	Recruiting	2018-03	Norway
Effect of a Liberal Fasting Regime (Sip-til-Send) on Preoperative Gastric Volume Measured Using Point of Care Ultrasound NCT07656649 · ClinicalTrials.gov ↗ · Fasting Status	Observational	Recruiting	2026-06	Norway
Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia NCT04463498 · ClinicalTrials.gov ↗ · Sleep Disorder; Insomnia Type, Psychiatric Disorders	Not applicable	Recruiting	2021-12	Norway
NADream: Effects of Nicotinamide Adenine Dinucleotide Supplementation on Sleep Quality in Healthy Individuals NCT06971224 · ClinicalTrials.gov ↗ · Sleep	Phase 2	Recruiting	2025-10	Norway
Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy NCT05388461 · ClinicalTrials.gov ↗ · Depressive Disorder	Observational	Recruiting	2013-03	Norway
Exercise Therapy in Mental Disorders-study NCT06313918 · ClinicalTrials.gov ↗ · Schizophrenia and Related Disorders, Bipolar Disorder	Not applicable	Recruiting	2023-09	Norway
Enabling Parents of Children With Autism Spectrum Disorders - a Randomized Controlled Trial of Parenting Programs NCT05750095 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder	Not applicable	Recruiting	2022-01	Norway
MicroRNA as Markers in Testicular Cancer NCT04914026 · ClinicalTrials.gov ↗ · Testicular Germ Cell Cancer, Seminoma, Non-Seminoma Testicular Cancer	Observational	Recruiting	2016-12	Sweden, Norway
eCardiacRehab - a Hybrid Patient-Centered eHealth Programme NCT07590635 · ClinicalTrials.gov ↗ · Comorbidities and Coexisting Conditions, Ethics, Continuity of Patient Care	Not applicable	Recruiting	2026-05	Norway
Rituximab and Ocrelizumab in Serum With Multiple Sclerosis NCT06663111 · ClinicalTrials.gov ↗ · Relapsing Remitting Multiple Sclerosis	Observational	Recruiting	2021-03	Norway
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism NCT05368090 · ClinicalTrials.gov ↗ · Primary Aldosteronism, Aldosterone-Producing Adenoma, Hypercortisolism	Not applicable	Recruiting	2022-06	Norway
The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism NCT06162013 · ClinicalTrials.gov ↗ · Progressive Supranuclear Palsy, Multiple System Atrophy, Corticobasal Syndrome	Phase 2	Recruiting	2024-03	Norway
Biomarker Guided Treatment in Gynaecological Cancer NCT02543710 · ClinicalTrials.gov ↗ · Endometrial Cancer	Phase 4	Recruiting	2015-10	Netherlands, Poland, Norway
Acellular Dermal Matrix vs Autologous Tarsus for Correction of Lower Eyelid Retraction NCT06926686 · ClinicalTrials.gov ↗ · Lower Eyelid Retraction	Not applicable	Recruiting	2025-01	Norway
Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial NCT06315075 · Self-harm, Suicidal Ideation, Suicide and Self-harm	Not applicable	Recruiting	2024-01	Norway
Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease NCT04936854 · Thyroid-Associated Ophthalmopathy Drugs: Methylprednisolone, Rapamycin, Sirolimus	Phase 2	Recruiting	2023-01	Norway
A Digital Treatment for Adolescents With Eating Disorders NCT06306586 · ClinicalTrials.gov ↗ · Eating Disorders	Not applicable	Recruiting	2024-03	Norway
The NADage Study: Nicotinamide Riboside Replenishment Therapy Against Functional Decline in Aging NCT06208527 · ClinicalTrials.gov ↗ · Frailty, Frail Elderly Syndrome, Frailty Syndrome	Phase 2	Recruiting	2025-01	Norway
HelpILO - RCT on EILO Treatment NCT04620343 · ClinicalTrials.gov ↗ · Exercise Induced Laryngeal Obstruction (EILO)	Not applicable	Recruiting	2021-01	Norway
Weber B Ankle Fractures With Associated Posterior Malleolus Fracture NCT05413707 · ClinicalTrials.gov ↗ · Posterior Malleolus Fractures, Ankle Fractures, Syndesmotic Injuries	Not applicable	Recruiting	2023-03	Norway
A Handheld Tool for Active Distraction of Children and Adolescents During Painful Procedures NCT06984939 · ClinicalTrials.gov ↗ · Pain	Not applicable	Recruiting	2025-05	Norway
Right Colectomy for Colon Cancer Database (RCC). Surgical Technique, Route of Access and Quality of the Specimen NCT06329102 · ClinicalTrials.gov ↗ · Right Sided Colon Cancer, Right Colectomy, Lymphadenectomy	Observational	Recruiting	2021-01	Norway
Sleep in Psychiatric Care (SIP): Treatment for Comorbid Delayed Sleep-Wake Phase Disorder (DSWPD) NCT05177055 · ClinicalTrials.gov ↗ · Delayed Sleep-Wake Phase Disorder, Sleep Disorder, Psychiatric Disorder	Not applicable	Recruiting	2022-05	Norway
Promoting Mental Health in Young Children - a Dialogue Based Approach in Kindergartens NCT06471816 · Child Behavior, Child Development	Not applicable	Recruiting	2024-01	Norway
A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care NCT06299189 · ClinicalTrials.gov ↗ · ADHD, ADHD - Combined Type, ADHD Predominantly Inattentive Type	Not applicable	Recruiting	2024-01	Norway
Evaluating the Big Five Intervention in Norway NCT07151573 · ClinicalTrials.gov ↗ · Anxiety Depression	Not applicable	Recruiting	2025-09	Norway
The Key to Integrated Trauma Treatment in Psychosis Trial NCT06608706 · ClinicalTrials.gov ↗ · Psychiatric Diagnosis, Schizophrenia Disorders, Psychological Trauma, Historical	Not applicable	Recruiting	2024-09	Norway
Total Neoadjuvant Treatment Combined With Adaptive Radiotherapy for Rectal Cancer NCT05883800 · ClinicalTrials.gov ↗ · Rectal Cancer	Not applicable	Recruiting	2023-06	Norway
Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17) NCT03643549 · ClinicalTrials.gov ↗ · Glioblastoma	Phase 1/2	Recruiting	2018-08	Norway
Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis NCT05740722 · ClinicalTrials.gov ↗ · Multiple Sclerosis, Progressive Multiple Sclerosis	Phase 2	Recruiting	2023-05	Norway
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity NCT07042672 · ClinicalTrials.gov ↗ · Binge Eating Disorder Associated With Obesity, Binge Eating Disorder, Eating Disorder Binge Drug: GLP-1	Observational	Recruiting	2025-07	Norway
A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients NCT06199557 · ClinicalTrials.gov ↗ · Acute Myeloid Leukemia, Adult, Myelodysplastic Syndromes, Adult Drugs: Mercaptopurine, Valproic acid	Phase 1/2	Recruiting	2024-05	Norway
Reestablishing Normal Gut-brain Interaction in Anorexia Nervose With Normal Gut Microbiota NCT07574892 · ClinicalTrials.gov ↗ · Anorexia Nervosa	Phase 1	Not yet open	2026-12	Norway
The Intravenous Amino Acid Therapy for Vascular Rigidity in End Stage Renal Disease NCT07392697 · ClinicalTrials.gov ↗ · Chronic Kidney Disease Requiring Chronic Dialysis, Cardiovascular Calcification	Not applicable	Not yet open	2026-02	Norway
Ureteroscopic Lithotripsy for Renal Stones Using a Sheathless Approach or Using a Flexible and Navigable Ureteral Access Sheath (FANS) NCT07741084 · ClinicalTrials.gov ↗ · Renal Stones	Not applicable	Not yet open	2026-08	Norway
Digital Intervention Targeting Cancer-related Cognitive Impairments NCT06693102 · ClinicalTrials.gov ↗ · Cancer, Cognitive Impairment	Not applicable	Not yet open	2025-01	Norway
Feasibility of a Digital Intervention for Patients Frequently Admitted to Psychiatric Acute Wards NCT06998654 · ClinicalTrials.gov ↗ · Mental Health Help-Seeking, Digital Health, Readmissions	Not applicable	Not yet open	2025-06	Norway
The NorCUP Trial: Improving Prognosis and Personalized Treatment in Cancer of Unknown Primary (CUP) NCT07366008 · ClinicalTrials.gov ↗ · Cancer of Unknown Primary Site	Not applicable	Not yet open	2026-01	Norway
Emergency Medicine Evaluation for Acute Abdominal Pain - a Pragmatic Randomized Trial NCT07815795 · ClinicalTrials.gov ↗ · Abdominal Pain (AP), Acute Abdomen, Acute Abdominal Pain	Not applicable	Not yet open	2026-09	Norway
Assess the Efficacy of Tailored Patient Information and Voluntary Patient-managed Outpatient Digital Follow-up (I-POD) as an Adjunct to Standard Treatment According to National Guidelines in the National Trauma Plan Among Adult Trauma Patients in Norway. NCT07268716 · ClinicalTrials.gov ↗ · Trauma Centers, Trauma Patients, Trauma (Including Fractures)	Not applicable	Not yet open	2026-12	Norway
Intensive Dialectical Behavior Therapy for Self-Harm and Suicidal Behavior in Youth: A Pilot Study NCT07450105 · ClinicalTrials.gov ↗ · Self-Harm, Deliberate, Suicidal Behavior, Borderline Personality Disorder (BPD)	Not applicable	By invitation	2026-03	Norway
Active External Rewarming from Accidental Hypothermia - a Dose-response Pilot Study NCT06855173 · ClinicalTrials.gov ↗ · Accidental Hypothermia	Not applicable	By invitation	2025-03	Norway
Blood Biomarkers in Electroconvulsive Therapy NCT05515159 · ClinicalTrials.gov ↗ · Electroconvulsive Therapy, Depression, Blood Biomarkers	Observational	By invitation	2019-10	Norway
Physical Activity Based Treatment for Youth With Depression and Anxiety NCT07304219 · ClinicalTrials.gov ↗ · Anxiety Depression	Not applicable	By invitation	2025-12	Norway
Prehospital Use of Forced Air Warming NCT07450092 · ClinicalTrials.gov ↗ · Hypothermia Due to Cold Environment	Not applicable	By invitation	2026-03	Norway
Invest-CTO PCI Trial NCT04774913 · Chronic Total Occlusion of Coronary Artery, Angina Pectoris, Quality of Life	Not applicable	Active, closed	2021-12	Norway
Robotized Navigation Compared to Conventional Technique in Total Knee Replacement NCT04525950 · ClinicalTrials.gov ↗ · Arthritis, Degenerative, Osteo Arthritis Knee	Not applicable	Active, closed	2020-09	Norway
PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway NCT05852873 · ClinicalTrials.gov ↗ · Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection, COVID-19 Drugs: Nirmatrelvir/ritonavir, Paxlovid	Phase 3	Active, closed	2023-05	Norway
Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS) NCT03477500 · ClinicalTrials.gov ↗ · Multiple Sclerosis Drugs: Alemtuzumab, Mavenclad, Ocrelizumab	Phase 3	Active, closed	2018-03	Netherlands, Sweden, Denmark, Norway
The p53 Breast Cancer Trial NCT02965950 · ClinicalTrials.gov ↗ · Locally Advanced Breast Cancer, Metastatic Breast Carcinoma Drug: Cyclophosphamide	Phase 2	Active, closed	2016-10	Norway
Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis NCT04749667 · ClinicalTrials.gov ↗ · Multiple Sclerosis, Progressive Multiple Sclerosis	Phase 1/2	Active, closed	2021-08	Norway
Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco NCT05290025 · ClinicalTrials.gov ↗ · Smoking Cessation, Substance-Related Disorders Drug: Nicotine	Not applicable	Active, closed	2022-04	Norway
The NORDSTEN Studies/The Observational Cohort Study NCT03562936 · ClinicalTrials.gov ↗ · Degenerative Lumbar Spinal Stenosis, Degenerative Spondylolisthesis	Observational	Active, closed	2014-02	Norway
PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial NCT02624973 · ClinicalTrials.gov ↗ · Breast Cancer Drugs: Cyclophosphamide, Goserelin, Palbociclib	Phase 2	Active, closed	2016-04	Norway
Mechanisms of Anaphylaxis NCT03182491 · ClinicalTrials.gov ↗ · Anaphylaxis, Allergy, Transfusion Reaction	Observational	Active, closed	2017-04	Norway
Intensive Care of Elderly: What do They Wish for Themselves? NCT05149040 · ClinicalTrials.gov ↗ · Aged, 80 and Over, Critical Illness	Observational	Active, closed	2021-11	Norway
The INFLUENCE of Cytoreduction on PRO in EOC NCT03268876 · ClinicalTrials.gov ↗ · Epithelial Ovarian Cancer	Observational	Active, closed	2021-03	Norway
The NORDSTEN Study - Degenerative Spondylolisthesis NCT02051374 · ClinicalTrials.gov ↗ · Lumbar Degenerative Spondylolisthesis	Not applicable	Active, closed	2014-02	Norway
Feasibility Trial of a Guided Internet-delivered Intervention for Adolescents With ADHD NCT06711224 · ClinicalTrials.gov ↗ · ADHD	Not applicable	Active, closed	2024-11	Norway
Degenerative Spondylolisthesis; Micro-decompression vs Decompression + Instrumented Fusion; Long Term Follow up NCT03469791 · ClinicalTrials.gov ↗ · Degenerative Lumbar Spondylolisthesis	Not applicable	Active, closed	2007-09	Norway
Artificial Intelligence (AI) Support in Medical Emergency Calls NCT04648449 · ClinicalTrials.gov ↗ · Stroke, Acute, Apoplexy; Brain, Emergencies	Observational	Active, closed	2020-09	Norway
The NORDSTEN Studies/ The Spinal Stenosis Study NCT02007083 · ClinicalTrials.gov ↗ · Lumbar Spinal Stenosis	Not applicable	Active, closed	2013-11	Norway
Donor Selection for Faecal Microbiota Transplantation in Irritable Bowel Syndrome NCT06171126 · ClinicalTrials.gov ↗ · Irritable Bowel Syndrome	Not applicable	Active, closed	2024-02	Norway
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study NCT03810599 · Coronary Artery Disease	Not applicable	Active, closed	2013-09	Norway
Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease NCT04578639 · ClinicalTrials.gov ↗ · Relapsing Remitting Multiple Sclerosis Drugs: Ocrelizumab, Rituximab	Phase 3	Active, closed	2020-11	Sweden, Norway
A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study NCT05095571 · ClinicalTrials.gov ↗ · Amyotrophic Lateral Sclerosis	Not applicable	Active, closed	2021-10	Norway
NOPARK Open Label Extension Study NCT05546567 · ClinicalTrials.gov ↗ · Safety Issues	Not applicable	Active, closed	2022-09	Norway
The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS. NCT04562831 · ClinicalTrials.gov ↗ · Amyotrophic Lateral Sclerosis	Not applicable	Active, closed	2020-10	Norway
Patient-reported Outcomes After Percutaneous Coronary Intervention NCT03810612 · ClinicalTrials.gov ↗ · Coronary Artery Disease	Observational	Active, closed	2017-06	Denmark, Norway
NOR-SYS: The Norwegian Stroke in the Young Study NCT01597453 · ClinicalTrials.gov ↗ · Death, Carotid Artery Disease, Cardiovascular Disease	Not applicable	Active, closed	2010-09	Norway
Digital Treatment of Irritable Bowel Syndrome (IBS) NCT06117865 · ClinicalTrials.gov ↗ · IBS - Irritable Bowel Syndrome	Not applicable	Active, closed	2023-12	Norway
Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study NCT06759805 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Cardiac Rehabilitation, Ethics	Not applicable	Active, closed	2025-01	Norway

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Haukeland University Hospital trials

19 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Cyclophosphamide2 Ocrelizumab2 Alemtuzumab1 GLP-11 Goserelin1 Mavenclad1 Mercaptopurine1 Methylprednisolone1 Nicotine1 Nirmatrelvir/ritonavir1 Palbociclib1 Paxlovid1 Pertuzumab1 Rapamycin1 Rituximab1 Sirolimus1 Solu-Medrol1 Trastuzumab1 Valproic acid1

Conditions in Haukeland University Hospital trials

150 conditions

Multiple Sclerosis3 Coronary Artery Disease3 Amyotrophic Lateral Sclerosis3Relapsing Remitting Multiple Sclerosis2Primary Aldosteronism2Hypercortisolism2Progressive Multiple Sclerosis2ADHD2Ethics2Continuity of Patient Care2Eating Disorders2Anxiety Depression2Endometrial Cancer1Testicular Germ Cell Cancer1Seminoma1Non-Seminoma Testicular Cancer1Stage I Testicular Cancer1Chronic Total Occlusion of Coronary Artery1Angina Pectoris1Quality of Life1PROM1Arthritis, Degenerative1Osteo Arthritis Knee1Anxiety1

By trial register

Register	Trials	Recruiting
Clinical trials in Norway	80	40
Clinical trials in Sweden	3	1
Clinical trials in Netherlands	2	1
Clinical trials in Denmark	2	0
Clinical trials in Poland	1	1

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Multiple Sclerosis

Sponsor	Trials
Novartis Pharmaceuticals	10
Hoffmann-La Roche	9
IRCCS San Raffaele	5
Assistance Publique Hopitaux De Marseille	5
Hacettepe University	5
University of Calgary	4
Heinrich-Heine University, Duesseldorf	4
Fondazione Don Carlo Gnocchi ETS	4
Firat University	4
Selcuk University	4

Sponsors with the most current trials registered for this condition.

Questions about Haukeland University Hospital trials

How many clinical trials does Haukeland University Hospital sponsor?

Haukeland University Hospital is the lead sponsor of 80 current trials on ClinicalTrials.gov in our Norway, Sweden, Netherlands, Denmark and Poland registers, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.

Are Haukeland University Hospital trials recruiting?

Yes. 40 of its 80 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Haukeland University Hospital testing?

Its current trials name 19 drugs and biologicals as interventions. The most frequent are Cyclophosphamide (2), Ocrelizumab (2), Alemtuzumab (1), GLP-1 (1) and Goserelin (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.